Interim Management Statement Q1 2017 Release no.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
131
Interim Management Statement Q1 2017

Release no. 15/2017

In accordance with the regulations for listed companies’ submission of interim statements, Columbus A/S hereby submits the interim management statement for the period 01.01.2017-31.03.2017 (3 months).

Release no. 15, 2017 – Interim Management Statement for Q1 2017 April 25th, 2017

Growth driven by the services business

Revenue in Q1 2017 amounted to DKK 310m (2016: DKK 275m), corresponding to an increase of 13% compared to the same period last year. EBITDA* amounted to  DKK 29m (2016: DKK 26m), corresponding to an increase of 14%.

The revenue growth was primarily driven by a solid growth in revenue in the services business of 18%.

The increase in EBITDA was also driven by an increase in earnings in the services business of 33%.

Financial value drivers (KPI’s)

In connection with the Columbus2020 strategy, the Group has determined three value drivers, which reflect the strategic direction. The value drivers measure the development in relation to significant success criteria for future growth and value creation.

  • Improve profitability in the services business
  • Scaling of own software sales
  • Growth in recurring revenue

Below, the development in these three financial value drivers are reviewed.

Growth and increased earnings in the services business

In Q1 2017 the revenue in the services business increased by 18% to DKK 225m (2016: DKK 192m). The increase primarily came from an increase in realized hourly rates and the effect from acquisitions made in 2016 and 2017.

In Q1 2017 the service EBITDA increased from  DKK 20m to DKK 26m, an increase of 33%. The increase primarily came from the higher realized hourly rates and acquisitions. Furhermore, a major parameter for the improvement in the Service EBITDA was increased utilization of Columbus’ Global Delivery Center in India.

Chargeable hours declined from 58% to 55% in the first quarter of the year, affected by a decrease in chargeable hours in the US SMB business, as well as by a normalization of the chargeable hours in England and Russia.   

Columbus Software sales increased by  5% I n Q1 2017 the sale of Columbus Software increased by 5%. As a consequence of the cloud conversion license sales decreased by 20%. However, the cloud revenue increased to DKK 664,000.

The revenue from subscriptions increased by  17% due to a satisfactory renewal rate of previous year’s sale of licenses. The sale of Columbus Software developed according to plan.

Growth in recurring revenue

The recurring revenue consists of  Columbus Software subscriptions, third party software subscriptions, cloud revenue, hosting revenue and ColumbusCare contracts.

Recurring revenue increased by 17%.

The sale of ColumbusCare contracts increased significantly by 62%, which is a satisfactory development.

Recurring revenue constituted 24.4% of total revenue (2016: 23.6%). The development is according to plan.

Acquisitions in 2017 In January 2017 Columbus acquired the US IT services company, Tridea Partners, which holds a leading positon within ERP and CRM in the growing food and beverage industry in the US.

Columbus maintains expectations to  2017

Columbus maintains the announced expectations to revenue, EBITDA1, Service EBITDA and dividend in 2017:

  • Revenue in the level of DKK 1.35bn.
  • EBITDA* in the level of DKK 150m.
  • Service EBITDA of DKK 80m.
  • 10% dividend on nominal share capital

Latest developmentsNo events or transactions with a material effect on the company’s financial position have occurred since the balance sheet date.

*EBITDA before share-based payment

DKK ´000 Q1 2017 Q1 2016 2016
Columbus licenses 6,387 7,973 44,187
Columbus subscriptions 12,859 10,417 46,876
External licenses 16,967 18,210 86,495
External subscriptions 42,995 42,108 195,164
Services 225,089 191,557 796,401
Other 5,755 5,066 23,584
Total net revenue 310,053 275,331 1,192,707
       
EBITDA before share-based payment 29,454 25,908 144,070
Share-based payment -597 -546 -5,524
EBITDA 28,857 25,362 138,546
Ib Kunøe Chairman Columbus A/S   Thomas Honoré CEO & President Columbus A/S
For further information, please contact: CEO & President, Thomas Honoré .: +45 70 20 50 00  
Translation: In the event of any inconsistency between this document and the Danish language version, the Danish language version shall be the governing version.
Income statement
DKK ´000 Q1 2017 Q1 2016 2016
       
Net revenue 310,053 275,331 1,192,707
External project costs -60,371 -52,677 -264,601
Gross profit 249,682 222,654 928,106
       
Staff expenses and remuneration -178,584 -160,439 -631,675
Other external costs -41,669 -36,223 -158,982
Other operating income 25 0 6,685
Other operating costs 0 -84 -64
EBITDA before share-based payment 29,454 25,908 144,070
       
Share-based payment -597 -546 -5,524
EBITDA 28,857 25,362 138,546
       
Depreciation -9,778 -7,501 -33,275
Operating profit (EBIT) 19,079 17,861 74,843
       
Financial income 18 90 2,674
Financial expense -2,388 -1,754 -642
Profit before tax 16,709 16,197 107,303

Financial income and expenses

Financial income and expenses primarily concerns exchange rate adjustments in relation to group receivables and monetary items.

Balance sheet
DKK ´000 Q1 2017 Q1 2016 2016
       
ASSETS      
       
Goodwill 464,391 339,962 415,152
Customer base 34,370 29,977 30,562
License rights 19 0 17
Development projects finalized 64,541 55,781 59,354
Development projects in progress 5,310 5,319 8,491
Property, plant and equipment 15,975 16,293 17,142
Deferred tax assets 21,086 18,581 17,053
Total non-current assets 605,692 465,913 547,771
       
Inventories 688 1,228 205
       
Trade receivables 136,582 119,950 151,475
Contract work in progress 13,815 17,858 8,994
Corporate tax receivables 6,429 346 11,531
Deferred tax assets 3,400 7,500 7,500
Other receivables 7,107 10,368 8,155
Prepayments 13,711 10,622 7,206
Receivables 181,044 166,644 194,861
       
Cash 64,918 52,333 94,669
       
Total current assets 246,650 220,205 289,735
       
TOTAL ASSETS 852,342 686,118 837,506
Balance sheet
DKK ´000 Q1 2017 Q1 2016 2016
       
EQUITY AND LIABILITIES      
       
Share capital 149,832 142,123 145,247
Reserves on foreign currency translation -7,163 -16,302 -6,475
Retained profit 360,454 270,400 331,041
Group shareholders’ equity 503,123 396,221 469,813
Minority interests 2,653 2,791 1,774
Equity 505,776 399,012 471,587
       
Deferred tax 10,619 6,436 10,614
Provisions 18,008 13,049 11,532
Non-current liabilities 28,627 19,485 22,146
       
Debt to credit institutions 20,607 1,302 29,091
Client prepayments 27,885 30,077 33,645
Trade payables 48,033 43,080 66,211
Corporate tax payables 19,209 9,528 24,177
Other liabilities 157,118 151,660 157,228
Accruals 45,087 31,974 33,421
Current liabilities 317,939 267,621 343,773
       
Total liabilities 346,566 287,106 365,919
       
TOTAL EQUITY AND LIABILITIES 852,342 686,118 837,506

In order to support decisions about allocation of resources and assessment of performance of the segments, the Group’s internal reporting to the Board of Directors of the Parent Company is based on the following grouping of operating segments:

Strategic business areas Description       Geographical segment
ISV (Independent Software Vendor) Development and sale of industry-specific software within Columbus' three focus industries: Retail, food and manufacturing No specific area
Consultancy Sale, implementation and service of standard business systems. Western Europe Eastern Europe North America
Information about the Group’s segments is stated below.
             
    Consultancy    
DKK ´000 ISV Western Europe Eastern Europe North America HQ, GDC and Eliminations Total
             
Q1 2017            
             
Columbus Software licenses 5,523 2,777 721 159 -2,793 6,387
Columbus Software subscriptions 10,020 4,151 449 1,257 -3,018 12,859
External licenses 0 5,031 3,523 8,481 -68 16,967
External subscriptions 0 12,414 5,138 25,450 -7 42,995
Services 4,177 119,095 25,662 79,530 -3,375 225,089
Other 283 2,645 423 2,688 -284 5,755
Total net revenue 20,003 146,113 35,916 117,565 -9,545 310,053
             
Gross profit 16,949 114,996 28,095 82,783 6,859 249,682
EBITDA 9,679 18,055 4,279 3,941 -7,097 28,857
             
             
    Consultancy    
DKK ´000 ISV Western Europe Eastern Europe North America HQ, GDC and Eliminations Total
             
Q1 2016            
             
Columbus Software licenses 6,678 2,157 378 417 -1,657 7,973
Columbus Software subscriptions 9,107 2,758 321 1,078 -2,847 10,417
External licenses 0 5,140 2,119 10,964 -13 18,210
External subscriptions 0 15,104 4,807 22,284 -87 42,108
Services 3,869 109,570 20,998 63,389 -6,269 191,557
Other 196 2,330 409 2,082 49 5,066
Total net revenue 19,850 137,059 29,032 100,214 -10,824 275,331
             
Gross profit 18,976 105,945 23,011 67,480 7,242 222,654
EBITDA 9,696 13,934 2,427 5,278 -5,973 25,362
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 99

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Analyzing RTX: Trends in Short Interest and Market Sentiment

Updated Category News Views 176

Understanding RTX's Recent Market Movements RTX Corp has seen a notable shift in its market dynamics recently. The company's short interest, defined as the number of shares sold short but not yet covered, has decreased by 7.63% since the last reporting period. Currently, there are approximately 16.18 million shares sold short, equating to 1.21% of all shares available for...

Continue Reading
Celebrate Christmas Spirit with Personalized PrayerSongs

Updated Category News Views 156

Celebrate the Joy of Christmas with PrayerSong Bring Love Into Your Home with a PrayerSong for Your Family and Friends When the holiday season arrives, the focus shifts beyond material gifts. Instead, it’s about nurturing connections filled with love, faith, and meaningful moments. This Christmas, PrayerSong provides families with a unique opportunity to honor loved...

Continue Reading
Understanding the Short Selling Landscape of Analog Devices

Updated Category News Views 153

Analyzing Short Interest for Analog Devices As investors navigate the ever-changing stock market, understanding short interest can provide valuable insights into market sentiment regarding Analog Devices (NYSE: ADI). Recently, it was reported that Analog Devices has seen a notable increase of 4.11% in its short percent of float. Currently, there are approximately 7.52...

Continue Reading
Future of Clinical Trials: Exploring Market Growth to USD 85.37 Billion

Updated Category News Views 71

Understanding Clinical Trials and Their Importance Clinical trials serve as a fundamental pillar in advancing medical knowledge and enhancing patient care. These trials encompass a detailed and thorough process involving participant recruitment, intervention administration, data collection, and result analysis. The outcomes produced from clinical trials play a crucial...

Continue Reading